1. Home
  2. CCCC vs GUT Comparison

CCCC vs GUT Comparison

Compare CCCC & GUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • GUT
  • Stock Information
  • Founded
  • CCCC 2015
  • GUT 1999
  • Country
  • CCCC United States
  • GUT United States
  • Employees
  • CCCC N/A
  • GUT N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • GUT Trusts Except Educational Religious and Charitable
  • Sector
  • CCCC Health Care
  • GUT Finance
  • Exchange
  • CCCC Nasdaq
  • GUT Nasdaq
  • Market Cap
  • CCCC 396.0M
  • GUT 398.9M
  • IPO Year
  • CCCC 2020
  • GUT N/A
  • Fundamental
  • Price
  • CCCC $3.95
  • GUT $5.24
  • Analyst Decision
  • CCCC Buy
  • GUT
  • Analyst Count
  • CCCC 6
  • GUT 0
  • Target Price
  • CCCC $10.67
  • GUT N/A
  • AVG Volume (30 Days)
  • CCCC 1.9M
  • GUT 176.3K
  • Earning Date
  • CCCC 10-31-2024
  • GUT 01-01-0001
  • Dividend Yield
  • CCCC N/A
  • GUT 10.93%
  • EPS Growth
  • CCCC N/A
  • GUT N/A
  • EPS
  • CCCC N/A
  • GUT N/A
  • Revenue
  • CCCC $33,668,000.00
  • GUT N/A
  • Revenue This Year
  • CCCC $75.79
  • GUT N/A
  • Revenue Next Year
  • CCCC N/A
  • GUT N/A
  • P/E Ratio
  • CCCC N/A
  • GUT N/A
  • Revenue Growth
  • CCCC 65.45
  • GUT N/A
  • 52 Week Low
  • CCCC $3.61
  • GUT $4.60
  • 52 Week High
  • CCCC $11.88
  • GUT $7.38
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 41.77
  • GUT 48.33
  • Support Level
  • CCCC $3.61
  • GUT $5.03
  • Resistance Level
  • CCCC $4.06
  • GUT $5.47
  • Average True Range (ATR)
  • CCCC 0.44
  • GUT 0.12
  • MACD
  • CCCC 0.01
  • GUT -0.03
  • Stochastic Oscillator
  • CCCC 22.82
  • GUT 46.59

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

About GUT Gabelli Utility Trust (The)

Gabelli Utility Trust operates as a diversified closed-end investment management company. The fund's primary objective is the long-term growth of capital and income. To achieve its objective, the fund may invest its assets in common stocks and other securities of foreign and domestic companies involved in providing products, services, or equipment for the generation or distribution of electricity, gas, & water; and telecommunications services or infrastructure operations. It invests in various sectors, of which Electric Integrated, Water, Telecommunications, and U.S. Government Obligations and others.

Share on Social Networks: